Downregulation of the expression of GLUT1 plays a role in apoptosis induced by sodium butyrate in HT-29 cell line

International Journal of Molecular Sciences

Volumn 7, Issue 2, 2006, Pages 59-70

  Li, Xi ^a   Luo, He Sheng ^a   Paul, Shelley C ^a   Tang, Tao ^a   Yuan, Guang Jin ^b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b Zhangzhou Medical and Nursing Vocational School   (China)

Author keywords

Apoptosis; Colon cancer; Glucose transporter; Monocarboxylate transporter1; Sodium butyrate

Indexed keywords

2 DEOXYGLUCOSE H 3; BUTYRIC ACID; DEOXYGLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; GLUCOSE TRANSPORTER 5; MONOCARBOXYLATE TRANSPORTER 1; PROTEIN BAX; PROTEIN BCL XL; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 34248181067     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/i7020059     Document Type: Article

References (36)

1. Jacobs, L.R. Fiber and colon cancer. Gastroenterol Clin. North. Am. 1988, 17, 747-60.
2. Hernandez, A.; Thomas, R.; Smith, F.; Sandberg, J.; Kim, S.; Chung, DH.; Evers, B.M. Butyrate sensitizes human colon cancer cells to TRAIL-mediated apoptosis. Surgery 2001, 130, 265-72.
3. Wang, Q.; Wang, X.; Hernandez, A.; Kim, S.; Evers, B.M. Inhibition of the phosphatidylinositol 3-kinase pathway contributes to HT29 andCaco-2 intestinal cell differentiation. Gastroenterology 2001, 120, 1381-1392.
4. Otaka, M.; Singhal, A.; Hakomori, S. Antibody-mediated targeting of differentiation inducers to tumor cells:inhibition of colonic cancer cell growth in vitro and in vivo. Biochem. Biophys. Res. Commun. 1989, 158, 202-208.
5. Vidyasagar, S.; Ramakrishna, B.S. Effects of butyrate on active sodium and chloride transport in rat and rabbitdistal colon. J. Physiol. 2002, 539, 163-173.
6. Scheppach, W.; Bartram, P.; Richter, A.; Richter, F.; Liepold, H.; Dusel, G.; Hofstetter, G.; Ruthlein, J.; Kasper, H. Effect of short-chain fatty acids on the human colonic mucosa in vitro.JPEN. J. Parenter. Entera. l. Nutr. 1992, 16, 43-48.
7. Butzner, J.D.; Meddings, J.B.; Dalal, V. Inhibition of short-chain fatty acid absorption and Na+ absorption during acute colitis in the rabbit. Gastroenterology 1994, 106, 1190-1198.
8. Duncan, S.H.; Louis, P.; Flint, H.J. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl. Environ. Microbiol. 2004, 70, 5810-5817.
9. Stein, J.; Zores, M.; Schroder, O. Short-chain fatty acid (SCFA) uptake into Caco-2 cells by a pH-dependent and carrier mediated transport mechanism. Eur. J. Nutr. 2000, 39, 121-125.
10. Younes, M.; Lechago, L.V.; Somoano , J.R.; Mosharaf , M.; Lechago, J. Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers. Cancer Res. 1996, 56, 1164-1167.
11. Bozzetti, F.; Gavazzi ,C.; Mariani, L.; Crippa, F. Glucose-based total parenteral nutrition does not stimulate glucose uptake by humans tumours.Clin. Nutr. 2004, 23, 417-421.
12. Noguchi, Y.; Marat, D.; Saito, A.; Yoshikawa, T.; Doi, C.; Fukuzawa, K.; Tsuburaya, A.; Satoh, S.; Ito, T. Expression of facilitative glucose transporters in gastric tumors.Hepatogastroenterology.1999, 46, 2683-2689.
13. Mellanen, P.; Minn, H.; Grenman, R.; Harkonen, P. Expression of glucose transporters in head-and-neck tumors.Int. J. Cancer. 1994, 6, 622-629.
14. Younes, M.; Brown, R.W.; Stephenson, M.; Gondo, M.; Cagle, P.T. Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival. Cancer 1997, 80, 1046-1051.
15. Brown, R.S.; Wahl, R.L. Overexpression of Glut-1 glucose transporter in human breast cancer.Cancer 1993, 72, 2979-2985.
16. Rivenzon-Segal, D.; Rushkin, E.; Polak-Charcon, S.; Degani, H. Glucose transporters and transport kinetics in retinoic acid-differentiated T47D human breast cancer cells. Am. J. Physiol. Endocrinol. Metab. 2000, 279, 508-519.
17. Kang, S.S.; Chun, Y.K.; Hur, M.H.; Lee, H.K.; Kim, Y.J.; Hong, S.R.; Lee, J.H.; Lee, S.G.; Park, Y.K. Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma.Jpn. J. Cancer Res. 2002, 93, 1123-1128.
18. Lambert, D.W.; Wood, I.S.; Ellis, A.; Shirazi-Beechey, S.P. Molecular changes in the expression of human colonic nutrient transporters during the transition from normality to malignancy. Br. J. Cancer 2002, 86, 1262-1269.
19. Hadjiagapiou, C.; Schmidt, L.; Dudeja, P.K.; Layden, T.J. Mechanism(s) of butyrate transport in Caco-2 cells: role of monocarboxylatetransporter 1. Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 279, 775-780.
20. Ritzhaupt, A.; Wood, I.S.; Ellis, A.; Hosie, K.B.; Shirazi-Beechey, S.P. Identification and characterization of a monocarboxylate transporter (MCT1) inpig and human colon: its potential to transport L-lactate as well as butyrate. J. Physiol. 1998, 513 , 719-732.
21. Cuff, M.A.; Lambert, D.W.; Shirazi-Beechey, S.P. Substrate-induced regulation of the human colonic monocarboxylate transporter,MCT1. J. Physiol. 2002, 539, 361-371.
22. Pellizzaro, C.; Coradini, D.; Daidone, M.G. Modulation of angiogenesis-related proteins synthesis by sodium butyrate in colon cancer cell line HT29. Carcinogenesis 2002, 23, 735-740.
23. Choi, J.W.; Yoon, D.J.; Lee, H.W.; Han, D.P.; Ahn, Y.H. Antisense GLUT1 RNA suppresses the transforming phenotypes of NIH 3T3 cells transformed by N-Ras. Yonsei Med. J. 1995, 36, 480-486.
24. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
25. Noguchi, Y.; Okamoto , T.; Marat, D.; Yoshikawa, T.; Saitoh, A.; Doi, C.; Fukuzawa, K.; Tsuburaya, A.; Satoh, S.; Ito, T. Expression of facilitative glucose transporter 1 mRNA in colon cancer was not regulated by k-ras. Cancer Lett. 2000, 154, 137-142.
26. Younes, M.; Lechago, L.V.; Lechago, Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases. J. Clin. Cancer Res. 1996, 2, 1151-1154.
27. Loberg, R.D.; Vesely, E.; Brosius, F.C. Enhanced glycogen synthase kinase-3beta activity mediates hypoxia-induced apoptosis of vascular smooth muscle cells and is prevented by glucose transport and metabolism. J. Biol. Chem. 2002, 277, 41667-41673.
28. Vander Heiden, M.G.; Plas, D.R.; Rathmell, J.C.; Fox, C.J.; Harris, M.H.; Thompson, C.B. Growth factors can influence cell growth and survival through effects on glucose metabolism. Mol. Cell. Biol. 2001, 21, 5899-5912.
29. Moley, K.H.; Mueckler, M.M. Glucose transport and apoptosis. Apoptosis 2000, 5, 99-105.
30. Takata, K.; Hirano, H. Mechanism of glucose transport across the human and rat placental barrier. Microsc. Res. Tech. 1997, 38, 145-152.
31. Sato, Y.; Ito, T.; Udaka, N.; Kanisawa, M.; Noguchi, Y.; Cushman, S.W.; Satoh, S. Immunohistochemical localization of facilitated-diffusion glucose transportersin rat pancreatic islets. Tissue Cell 1996, 28, 637-643.
32. Kovarikova, M.; Hofmanova, J.; Soucek, K.; Kozubik, A. The effects of TNF-alpha and inhibitors of arachidonic acid metabolism on human colon HT-29 cells depend on differentiation status. Differentiation 2004, 72, 23-31.
33. Ruemmele, F.M.; Schwartz, S.; Seidman, E.G.; Dionne, S.; Levy, E.; Lentze, M. J. Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway. Gut. 2003, 52, 94-100.
34. Munoz-Pinedo, C.; Ruiz-Ruiz, C.; Ruiz de Almodovar, C.; Palacios, C.; Lopez-Rivas, A. Inhibition of glucose metabolism sensitizes tumor cells to death receptor-triggered apoptosis through enhancement of death-inducing signalingcomplex formation and apical procaspase-8 processing. J. Biol. Chem. 2003, 278, 12759-12768.
35. Wacheck, V.; Selzer, E.; Gunsberg, P.; Lucas, T.; Meyer, H.; Thallinger, C.; Monia, B.P.; Jansen, B. Bcl-x(L) antisense oligonucleotides radiosensitise colon cancer cells. Br. J. Cancer 2003, 89, 1352-1357.
36. Zheng, S.Y.; Li, D.C.; Zhang, Z.D.; Zhao, J.; Ge, J.F. Adenovirus-mediated FasL gene transfer into human gastric carcinoma. World. J. Gastroenterol. 2005, 11, 3446-3450.